Vuzix Corporation (VUZI) announced that Kyocera (KYOCF) has developed a cardiac rehabilitation treatment in collaboration with Tokyo Medical Dental University that employs Vuzix Blade smart glasses. The system, developed in collaboration with Tomoyuki Umemoto and his colleagues in the Department of Cardiovascular Medicine at Tokyo Medical and Dental University, combines a Kyocera bone conduction headset with biometric sensing, Vuzix Blade smart glasses, and a small electrocardiograph. Patients undergoing cardiac rehabilitation therapy wear the headset and ECG, while physicians wear the smart glasses to monitor the biometric data. Abnormalities in pulse, oxygen saturation, and ECG can be detected visually and audibly, allowing the therapist to assist the patient with both hands free. Customized software displays various biological information on the smart glasses so that it can be grasped in an integrated manner.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on VUZI: